Cullen Investment Group, Ltd. Abbott Laboratories Transaction History
Cullen Investment Group, Ltd.
- $708 Billion
- Q2 2025
A detailed history of Cullen Investment Group, Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 3,707 shares of ABT stock, worth $497,775. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,707
Previous 4,000
7.32%
Holding current value
$497,775
Previous $531 Million
4.96%
% of portfolio
0.07%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding ABT
# of Institutions
3,582Shares Held
1.38BCall Options Held
9.71MPut Options Held
8.86M-
Vanguard Group Inc Valley Forge, PA170MShares$22.8 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.4 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.97 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.81 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $235B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...